Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
XBiotech's peak revenue was $44.0M in 2020. The peak quarterly revenue was $15.5M in 2020(2).
XBiotech's revenue increased from $44.0m in 2020 to $4.0M currently. That's a -90.89% change in annual revenue.
| Fiscal year / year | XBiotech revenue |
|---|---|
| 2020 | $44.0M |
| 2021 | $18.4M |
| 2022 | $4.0M |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2020 | - | - | - | - |
| 2021 | - | - | - | - |
| 2022 | - | - | - | - |
Do you work at XBiotech?
Did XBiotech meet its revenue projections?
| CEO | John Simard |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 56 |
| Date Founded | 2005 |
| Headquarters | Austin, Texas |
| Number of Locations | 1 |
| Revenue | $4.0M |
| Net Income | -$32,900,000 |
| Gross Proft | $3.4M (2022) |
| PE Ratio | -4.04 |
| Tax Rate | 0.0% |
| Market Capitalization | $155.5M |
| Total Assets | $246,103,000 |
| Ticker | XBIT |
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| AnaptysBio | - | $91.3M | 78 | - |
| Apexigen | - | $4.9M | 39 | - |
| KemPharm | - | $23.6M | 22 | - |
| Arisaph Pharmaceuticals | - | $680,000 | 8 | - |
| PDL BioPharma | - | $30.7M | 75 | - |
| Pulmatrix | - | $7.8M | 22 | - |
| Agenus | - | $103.0M | 294 | - |
| ZymoGenetics | - | $27.0M | 200 | - |
| Arena Pharmaceuticals | - | $54,000 | 194 | - |
| Icagen | - | $14.1M | 47 | - |
Zippia gives an in-depth look into the details of XBiotech, including salaries, political affiliations, employee data, and more, in order to inform job seekers about XBiotech. The employee data is based on information from people who have self-reported their past or current employments at XBiotech. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by XBiotech. The data presented on this page does not represent the view of XBiotech and its employees or that of Zippia.
XBiotech may also be known as or be related to XBIOTECH INC., XBIOTECH USA, INC., XBiotech, XBiotech Inc, XBiotech Inc., XBiotech, Inc. and Xbiotech Usa, Inc.